Which has better valuation and earnings, ALVOW or XOMAO?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is ALVOW or XOMAO more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A XOMA N/A N/A N/A

Does the media favor ALVOW or XOMAO?

In the previous week, Alvotech and Alvotech both had 1 articles in the media. XOMA's average media sentiment score of 1.20 beat Alvotech's score of 0.92 indicating that XOMA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alvotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive XOMA 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, APLMW or XOMAO?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is APLMW or XOMAO more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A XOMA N/A N/A N/A

Which has higher earnings and valuation, ARAV or XOMAO?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A XOMA $7.65M N/A N/A N/A N/A

Is ARAV or XOMAO more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A XOMA N/A N/A N/A

Which has better valuation & earnings, XOMAO or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is XOMAO or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Does the media favor XOMAO or BIAFW?

In the previous week, bioAffinity Technologies had 1 more articles in the media than XOMA. MarketBeat recorded 2 mentions for bioAffinity Technologies and 1 mentions for XOMA. XOMA's average media sentiment score of 1.20 beat bioAffinity Technologies' score of -0.66 indicating that XOMA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XOMA 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive bioAffinity Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative

Which has better valuation and earnings, XOMAO or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is XOMAO or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A BioVie N/A N/A N/A

Does the media favor XOMAO or BIVIW?

In the previous week, XOMA and XOMA both had 1 articles in the media. XOMA's average media sentiment score of 1.20 beat BioVie's score of 0.00 indicating that XOMA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XOMA 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioVie 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

XOMA (XOMAO) Competitors

$25.00 0.00 (0.00%)

As of 09/4/2026

Compare

XOMAO vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy XOMA stock or one of its competitors? XOMA's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does XOMA compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and XOMA (NASDAQ:XOMAO) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, Alvotech and Alvotech both had 1 articles in the media. XOMA's average media sentiment score of 1.20 beat Alvotech's score of 0.92 indicating that XOMA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alvotech	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
XOMA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Summary

Alvotech and XOMA tied by winning 1 of the 2 factors compared between the two stocks.

How does XOMA compare to Apollomics?

Apollomics (NASDAQ:APLMW) and XOMA (NASDAQ:XOMAO) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

In the previous week, XOMA had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Apollomics. XOMA's average media sentiment score of 1.20 beat Apollomics' score of 0.00 indicating that XOMA is being referred to more favorably in the news media.

Company	Overall Sentiment
Apollomics	Neutral
XOMA	Positive

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Summary

XOMA beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to Aravive?

Aravive (NASDAQ:ARAV) and XOMA (NASDAQ:XOMAO) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

In the previous week, XOMA had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for XOMA and 0 mentions for Aravive. XOMA's average media sentiment score of 1.20 beat Aravive's score of 0.00 indicating that XOMA is being referred to more favorably in the news media.

Company	Overall Sentiment
Aravive	Neutral
XOMA	Positive

Summary

XOMA beats Aravive on 3 of the 5 factors compared between the two stocks.

How does XOMA compare to bioAffinity Technologies?

XOMA (NASDAQ:XOMAO) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

In the previous week, bioAffinity Technologies had 1 more articles in the media than XOMA. MarketBeat recorded 2 mentions for bioAffinity Technologies and 1 mentions for XOMA. XOMA's average media sentiment score of 1.20 beat bioAffinity Technologies' score of -0.66 indicating that XOMA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
XOMA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
bioAffinity Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

Summary

XOMA beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to BioVie?

XOMA (NASDAQ:XOMAO) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

In the previous week, XOMA and XOMA both had 1 articles in the media. XOMA's average media sentiment score of 1.20 beat BioVie's score of 0.00 indicating that XOMA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
XOMA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioVie	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

Summary

XOMA beats BioVie on 2 of the 2 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XOMAO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XOMAO vs. The Competition

Export

Metric	XOMA	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$4.02B	$7.26B	$12.90B
Dividend Yield	9.00%	3.60%	2.53%	8.90%
P/E Ratio	N/A	12.71	273.83	25.45
Price / Sales	N/A	1,306.52	607.44	79.06
Price / Cash	N/A	107.40	77.39	52.28
Price / Book	N/A	16.15	12.85	6.17
Net Income	N/A	-$22.80M	$3.49B	$350.08M
7 Day Performance	N/A	0.31%	1.04%	-0.14%
1 Month Performance	N/A	8.25%	5.52%	1.02%
1 Year Performance	-1.96%	49.17%	24.39%	14.51%

XOMA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XOMAO XOMA	N/A	$25.00 flat	N/A	N/A	$0.00	$7.65M	N/A	10	Positive News
ALVOW Alvotech	N/A	$0.38 flat	N/A	-72.0%	$0.00	$491.95M	N/A	4
APLMW Apollomics	N/A	$0.01 -2.1%	N/A	+9.5%	$0.00	$8.50M	N/A	59	Positive News Gap Down
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.08 flat	N/A	+900.0%	$0.00	$5.85M	N/A	10

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XOMAO) was last updated on 9/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

XOMA (XOMAO) Competitors